Woodline Partners’s Cabaletta Bio CABA Stock Holding History

Woodline Partners’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.36M	Hold	1,250,242	–	–	0.01%	729
2025 Q4	$2.74M	Sell	1,250,242 -885,106	-41%	-$2.19M	0.01%	734
2025 Q3	$5M	Buy	2,135,348 +916,884	+75%	+$1.57M	0.02%	568
2025 Q2	$1.85M	Buy	+1,218,464	New	+$1.9M	0.01%	733
2024 Q3	–	Sell	-242,981	Closed	-$1.82M	–	612
2024 Q2	$1.82M	Buy	242,981 +318	+0.1%	+$3.9K	0.02%	426
2024 Q1	$4.14M	Buy	242,663 +1,210	+0.5%	+$26K	0.04%	379
2023 Q4	$5.48M	Buy	241,453 +107,269	+80%	+$1.8M	0.06%	307
2023 Q3	$2.04M	Buy	+134,184	New	+$1.83M	0.02%	399

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Woodline Partners's CABA Position: Q1 2026 in Review

Woodline Partners held its Cabaletta Bio (CABA) position steady in Q1 2026 at 1,250,242 shares worth $3.36M. The position accounts for 0.01% of the portfolio, ranked #729.

Woodline Partners first reported a position in CABA in Q3 2023 and has held it in 8 quarters since. The position peaked at $5.48M in Q4 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

Woodline Partners held 1,250,242 shares of Cabaletta Bio worth $3.36M as of Q1 2026.
Woodline Partners left its Cabaletta Bio share count unchanged in Q1 2026.
Cabaletta Bio made up 0.01% of Woodline Partners's portfolio in Q1 2026, its #729 holding.
Woodline Partners first reported a position in Cabaletta Bio in Q3 2023 and has held it in 8 quarters since.
Woodline Partners's Cabaletta Bio position peaked at $5.48M in Q4 2023.
108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.